{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T22:31:57Z","timestamp":1784241117431,"version":"3.55.0"},"reference-count":176,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":5444,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.fertnstert.2007.01.118","type":"journal-article","created":{"date-parts":[[2007,5,11]],"date-time":"2007-05-11T07:47:12Z","timestamp":1178869632000},"page":"1-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Safety of testosterone treatment in postmenopausal women"],"prefix":"10.1016","volume":"88","author":[{"given":"Glenn D.","family":"Braunstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2007.01.118_bib1","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1001\/jama.1941.02820520003002","article-title":"Androgen therapy in gynecology","volume":"117","author":"Geist","year":"1941","journal-title":"JAMA"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib2","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0002-9610(42)90305-2","article-title":"Treatment of female menopause with methyltestosterone and stilbestrol","volume":"56","author":"Kurzrok","year":"1942","journal-title":"Am J Surg"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib3","first-page":"665","article-title":"Androgenic therapy in women","volume":"2","author":"Greenblatt","year":"1942","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1210\/jcem-3-4-235","article-title":"Effects of androgens upon libido in women","volume":"3","author":"Salmon","year":"1943","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib5","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1210\/jcem-10-12-1547","article-title":"Evaluation of an estrogen, androgen, estrogen-androgen combination, and a placebo in the treatment of the menopause","volume":"10","author":"Greenblatt","year":"1950","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl","key":"10.1016\/j.fertnstert.2007.01.118_bib6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ghir.2006.03.009","article-title":"Androgen insufficiency in women","volume":"16","author":"Braunstein","year":"2006","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib7","first-page":"459","article-title":"Testosterone and libido in surgically and naturally menopausal women","volume":"2","author":"Alexander","year":"2006","journal-title":"Women\u2019s Health"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1055\/s-2006-939570","article-title":"Testosterone therapy for postmenopausal women: efficacy and safety","volume":"24","author":"Somboonporn","year":"2006","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib9","unstructured":"Advisory Committee for Reproductive Health Drugs. http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/04\/transcripts\/2004-4082T1.htm. December 2, 2004."},{"key":"10.1016\/j.fertnstert.2007.01.118_bib10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1055\/s-2007-1016265","article-title":"Risks of menopausal androgen supplementation","volume":"16","author":"Slayden","year":"1998","journal-title":"Semin Reprod Endocrinol"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1365-2265.2002.01584.x","article-title":"Effect of methyl testosterone administration on plasma viscosity in postmenopausal women","volume":"57","author":"Basaria","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib12","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib14","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/clinchem\/43.7.1289","article-title":"Endocrine aspects of anabolic steroids","volume":"43","author":"Wu","year":"1997","journal-title":"Clin Chem"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib16","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1210\/edrv.21.4.0404","article-title":"Role of hormones in pilosebaceous unit development","volume":"21","author":"Deplewski","year":"2000","journal-title":"Endocr Rev"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib17","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0300-595X(86)80029-9","article-title":"Pilosebaceous physiology in relation to hirsutism and acne","volume":"15","author":"Rosenfield","year":"1986","journal-title":"Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib18","first-page":"55","article-title":"Hirsutism and virilism in women","volume":"6","author":"Kirschner","year":"1984","journal-title":"Spec Top Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib19","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0149-2918(97)80125-7","article-title":"Androgen and estrogen-androgen hormone replacement therapy: a review of the safety literature, 1941 to 1996","volume":"19","author":"Gelfand","year":"1997","journal-title":"Clin Ther"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib20","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/0002-9378(47)90411-0","article-title":"Conservative treatment and therapeutic test for endometriosis by androgens","volume":"53","author":"Hirst","year":"1947","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib21","first-page":"152","article-title":"Pelvic endometriosis; treatment with methyl testosterone","volume":"2","author":"Preston","year":"1953","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib22","first-page":"577","article-title":"Methyl testosterone for migraine of women; report of sixty cases","volume":"54","author":"Moehlig","year":"1955","journal-title":"J Mich State Med Soc"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib23","first-page":"37","article-title":"Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women","volume":"81","author":"Raisz","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib24","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0029-7844(94)00448-M","article-title":"Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgical menopause","volume":"85","author":"Watts","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib25","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1089\/jwh.1996.5.593","article-title":"Interim safety analysis of a two-year study comparing oral estrogen-androgen and conjugated estrogens in surgically menopausal women","volume":"5","author":"Barrett-Connor","year":"1996","journal-title":"J Women\u2019s Health"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib26","first-page":"1012","article-title":"A two-year, double-blind comparison of estrogen-androgen and conjugated estrogens in surgically menopausal women","volume":"44","author":"Barrett-Connor","year":"1999","journal-title":"J Reprod Med"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib27","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1210\/jcem.87.4.8362","article-title":"Differential effects of oral estrogen versus oral estrogen-androgen replacement therapy on body composition in postmenopausal women","volume":"87","author":"Dobs","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib28","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/01.GME.0000153933.50860.FD","article-title":"Combined esterified estrogens and methyltestosterone versus esterified estrogens alone in the treatment of loss of sexual interest in surgically menopausal women","volume":"12","author":"Warnock","year":"2005","journal-title":"Menopause"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib29","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0015-0282(03)00358-3","article-title":"Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire","volume":"79","author":"Lobo","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib30","first-page":"919","article-title":"A comparison of esterified estrogens with and without methyltestosterone: effects on endometrial histology and serum lipoproteins in postmenopausal women","volume":"82","author":"Hickok","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib31","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00042192-200007040-00007","article-title":"Administration of testosterone undecanoate in postmenopausal women: effects on androgens, estrtadiol, and gonadotrophins","volume":"7","author":"Fl\u00f6ter","year":"2000","journal-title":"Menopause"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib32","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/cmt.5.4.357.365","article-title":"Addition of testosterone to estrogen replacement therapy in oophorectomized women: effects on sexuality and well-being","volume":"5","author":"Fl\u00f6ter","year":"2002","journal-title":"Climacteric"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib33","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0015-0282(01)01923-9","article-title":"Effects of androgen supplementation of hormone replacement therapy on the vascular reactivity of cerebral arteries","volume":"76","author":"Penotti","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib34","first-page":"2717","article-title":"Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: a pilot study","volume":"83","author":"Miller","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib35","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1056\/NEJM200009073431002","article-title":"Transdermal testosterone treatment in women with impaired sexual function after oophorectomy","volume":"343","author":"Shifren","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib36","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/archinte.165.14.1582","article-title":"Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial","volume":"165","author":"Braunstein","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib37","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1210\/jc.2004-1677","article-title":"Effects of testosterone replacement in human immunodeficiency virus-infected women with weight loss","volume":"90","author":"Choi","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib38","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/01.AOG.0000158103.27672.0d","article-title":"Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial","volume":"105","author":"Buster","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib39","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1210\/jc.2004-1747","article-title":"Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder","volume":"90","author":"Simon","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib40","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/01.gme.0000179049.08371.c7","article-title":"Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial","volume":"13","author":"Davis","year":"2006","journal-title":"Menopause"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib41","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/01.gme.0000243567.32828.99","article-title":"Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 study","volume":"143","author":"Shifren","year":"2006","journal-title":"Menopause"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib42","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/01.gme.0000168061.32917.83","article-title":"Effects of a romatase inhibition on sexual function and well-being in postmenopausal women treated with testosterone: a randomized, placebo-controlled trial","volume":"13","author":"Davis","year":"2006","journal-title":"Menopause"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib43","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/01.GME.0000060256.03945.20","article-title":"Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women","volume":"10","author":"Goldstat","year":"2003","journal-title":"Menopause"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib44","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.maturitas.2005.01.002","article-title":"Treatment with percutanous testosterone gel in postmenopausal women with decreased libido\u2014effects on sexuality and psychological general well-being","volume":"53","author":"Nathorst-Boos","year":"2006","journal-title":"Maturitas"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib45","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0306-4530(85)90009-5","article-title":"Sex steroids and affect in the surgical menopause: a double-blind, cross-over study","volume":"10","author":"Sherwin","year":"1985","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib46","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00006842-198707000-00009","article-title":"The role of androgen in the maintenance of sexual functioning in oophorectomized women","volume":"49","author":"Sherwin","year":"1987","journal-title":"Psychosom Med"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib47","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1136\/bmj.294.6577.936","article-title":"Effect of combined implants of oestradiol and testosterone on libido in postmenopausal women","volume":"294","author":"Burger","year":"1987","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib48","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0378-5122(94)00898-H","article-title":"Testosterone enhances estradiol\u2019s effects on postmenopausal bone density and sexuality","volume":"21","author":"Davis","year":"1995","journal-title":"Maturitas"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib49","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1210\/jcem.86.1.7103","article-title":"Evidence that parenteral testosterone therapy may improve endothelium-dependent and -independent vasodilation in postmenopausal women already receiving estrogen","volume":"86","author":"Worboys","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib50","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0020-7292(82)90199-0","article-title":"Endocrine and clinical effects of estradiol and testosterone pellets used in long-term replacement therapy","volume":"20","author":"Kapetanakis","year":"1982","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib51","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1365-2265.1998.00525.x","article-title":"The effects of low-dose testosterone treatment on lipid metabolism, clotting factors and ultrasonographic ovarian morphology in women","volume":"49","author":"Buckler","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib52","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0378-5122(84)90008-2","article-title":"The management of persistent menopausal symptoms with oestradiol-testosterone implants: clinical, lipid and hormonal results","volume":"6","author":"Burger","year":"1984","journal-title":"Maturitas"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib53","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0378-5122(84)90050-1","article-title":"The effects of subcutaneous hormone implants during climacteric","volume":"5","author":"Cardozo","year":"1984","journal-title":"Maturitas"},{"issue":"Suppl 4","key":"10.1016\/j.fertnstert.2007.01.118_bib54","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/S0015-0282(02)03002-9","article-title":"Randomized clinical trials of combined estrogen-androgen preparations: effects on sexual functioning","volume":"77","author":"Sherwin","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib55","first-page":"98","article-title":"Use of combined estrogen-androgen preparations in the postmenopause: evidence from clinical studies","volume":"43","author":"Sherwin","year":"1998","journal-title":"Int J Fertil Women\u2019s Med"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib56","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S0149-2918(97)80060-4","article-title":"Safety surveillance of esterified estrogens-methyltestosterone (Estratest and Estratest HS) replacement therapy in the United States","volume":"19","author":"Phillips","year":"1997","journal-title":"Clin Ther"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib57","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1210\/jc.2002-021967","article-title":"Endocrine treatment of transsexual people: a review of treatment regimens, outcomes, and adverse effects","volume":"88","author":"Moore","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib58","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF01542220","article-title":"Physical and hormonal evaluation of transsexual patients: a longitudinal study","volume":"15","author":"Meyer","year":"1986","journal-title":"Arch Sex Behav"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib59","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1046\/j.1365-2265.2003.01753.x","article-title":"Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects","volume":"58","author":"Elbers","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib60","first-page":"595","article-title":"Elevated serum testosterone, hirsutism, and virilism associated with combined androgen-estrogen hormone replacement therapy","volume":"77","author":"Urman","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib61","first-page":"474","article-title":"Elevated serum testosterone, hirsuitsm, and virilism associated with combined androgen-estrogen hormone replacement therapy","volume":"78","author":"Gelfand","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib62","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2273.1994.tb01153.x","article-title":"Virilization of the voice in post-menopausal women due to the anabolic steroid nandrolone decanoate (Decadurabolin)","volume":"19","author":"Gerritsma","year":"1994","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib63","first-page":"1025","article-title":"Methyl testosterone for migraine of women","volume":"48","author":"Moehlig","year":"1949","journal-title":"J Mich Med Soc"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib64","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1210\/er.2001-0025","article-title":"Androgens and coronary artery disease","volume":"24","author":"Wu","year":"2003","journal-title":"Endocr Rev"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib65","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1365-2796.1995.tb00871.x","article-title":"Hyperinsulinaemia and decreased plasma levels of dehydroepiandrosterone sulfate in premenopausal women with coronary heart disease","volume":"237","author":"Slowinska-Srzednicka","year":"1995","journal-title":"J Intern Med"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib66","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1161\/01.ATV.17.4.695","article-title":"Relationship between serum sex hormones and coronary artery disease in postmenopausal women","volume":"17","author":"Phillips","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib67","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1210\/jcem.84.6.5824","article-title":"Endogenous androgens and carotid intimal-medial thickness in women","volume":"84","author":"Bernini","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib68","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1161\/01.CIR.0000157697.54255.CE","article-title":"Sex-hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women aAcross the Nation (SWAN)","volume":"111","author":"Sutton-Tyrrell","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib69","doi-asserted-by":"crossref","first-page":"6064","DOI":"10.1210\/jc.2005-0765","article-title":"Androgens are associated with hemostatic and inflammatory factors among women at the mid-life","volume":"90","author":"Sowers","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib70","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/clinchem\/32.1.146","article-title":"Concentrations of sex-hormone binding globulin and corticosteroid binding globulin in serum in relation to cardiovascular risk factors and to 12-year incidence of cardiovascular disease and overall mortality in postmenopausal women","volume":"32","author":"Lapidus","year":"1986","journal-title":"Clin Chem"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib71","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0021-9150(94)90051-5","article-title":"Body fat distribution and its association with metabolic and hormonal risk factors in women with angiographically assessed coronary artery disease","volume":"105","author":"Hauner","year":"1994","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib72","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0002-9149(02)02490-6","article-title":"Relation of serum levels of sex hormone binding globulin to coronary heart disease in postmenopausal women","volume":"90","author":"Reinecke","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib73","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/aje\/155.5.437","article-title":"Endogenous postmenopausal hormones and carotid atherosclerosis: a case-control study of the Atherosclerosis Risk in Communities cohort","volume":"155","author":"Golden","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib74","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1161\/01.CIR.0000091114.36254.F3","article-title":"Sex hormone levels and risk of cardiovascular events in postmenopausal women","volume":"108","author":"Rexrode","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib75","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1136\/bmj.311.7014.1193","article-title":"Prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women","volume":"311","author":"Barrett-Connor","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib76","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1365-2265.1997.2601068.x","article-title":"Mortality and morbidity in transsexual subjects treated with cross-sex hormones","volume":"47","author":"van Kesteren","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib77","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/0026-0495(92)90271-B","article-title":"Relationship of sex hormone-binding globulin to lipid, lipoprotein, glucose, and insulin concentrations in postmenopausal women","volume":"41","author":"Haffner","year":"1992","journal-title":"Metabolism"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib78","first-page":"847","article-title":"Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy","volume":"43","author":"Sarrel","year":"1998","journal-title":"J Reprod Med"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib79","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.fertnstert.2005.12.039","article-title":"Effects of treatment with testosterone alone or in combination with estrogen on insulin sensitivity in postmenopausal women","volume":"86","author":"Zang","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib80","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0378-5122(94)00861-Z","article-title":"The impact of long-term testosterone replacement therapy on lipid and lipoprotein profiles in women","volume":"21","author":"Goh","year":"1995","journal-title":"Maturitas"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib81","first-page":"116","article-title":"The effects of hormone implants on serum lipoproteins and steroid hormones in bilaterally oophorectomised women","volume":"106","author":"Farish","year":"1984","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib82","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/0002-9378(87)90295-X","article-title":"Postmenopausal estrogen and androgen replacement and lipoprotein lipid concentrations","volume":"156","author":"Sherwin","year":"1987","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib83","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1530\/eje.0.1510029","article-title":"The influence of testosterone upon vascular reactivity","volume":"151","author":"Jones","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib84","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1161\/01.CIR.99.13.1666","article-title":"Acute anti-ischemic effect of testosterone in men with coronary artery disease","volume":"99","author":"Rosano","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib85","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0002-9149(98)00880-7","article-title":"Effect of acute testosterone on myocardial ischemia in men with coronary artery disease","volume":"83","author":"Webb","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib86","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0015-0282(98)80034-4","article-title":"Vasodilator effects of estrogen are not diminished by androgen in postmenopausal women","volume":"68","author":"Sarrel","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib87","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1210\/er.2003-0005","article-title":"Androgens and cardiovascular disease","volume":"24","author":"Liu","year":"2003","journal-title":"Endocr Rev"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib88","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/01.RES.84.11.1285","article-title":"Localized expression of aromatase in human vascular tissues","volume":"84","author":"Harada","year":"1999","journal-title":"Circ Res"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib89","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1161\/01.CIR.83.3.836","article-title":"Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease","volume":"83","author":"Yarnell","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib90","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/hrt.66.6.425","article-title":"Increased plasma viscosity and erythrocyte aggregation: indicators of an unfavourable clinical outcome in patients with unstable angina pectoris","volume":"66","author":"Neumann","year":"1991","journal-title":"Br Heart J"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib91","first-page":"206","article-title":"Viscosity and ischemic heart disease","volume":"4","author":"Rosenson","year":"1993","journal-title":"J Vasc Med Biol"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib92","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0002-9343(01)00643-X","article-title":"Hypertriglyceridemia and other factors associated with plasma viscosity","volume":"110","author":"Rosenson","year":"2001","journal-title":"Am J Med"},{"issue":"4 Suppl","key":"10.1016\/j.fertnstert.2007.01.118_bib93","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/S0025-6196(19)30669-X","article-title":"Safety and adverse effects of androgens: how to counsel patients","volume":"79","author":"Basaria","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib94","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.1210\/jc.2003-030520","article-title":"Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people","volume":"88","author":"Toorians","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib95","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1056\/NEJM197307122890205","article-title":"Androgens and erythropoiesis","volume":"289","author":"Shahidi","year":"1973","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib96","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1023\/A:1018704630036","article-title":"A follow-up study for estimating the effectiveness of a cross-gender hormone substitution therapy on transsexual patients","volume":"27","author":"Schlatterer","year":"1998","journal-title":"Arch Sex Behav"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib97","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/aje\/kwh250","article-title":"Glucose and insulin components of the metabolic syndrome are associated with hyperandrogenism in postmenopausal women: the atherosclerosis risk in communities study","volume":"160","author":"Golden","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib98","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.fertnstert.2006.01.010","article-title":"Effects of transdermal testosterone administration on insulin sensitivity, fat mass and distribution, and markers of inflammation and thrombolysis in human immunodeficiency virus-infected women with mild to moderate weight loss","volume":"85","author":"Herbst","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib99","first-page":"2198","article-title":"Exogenous androgens influence body composition and regional body fat distribution in obese postmenopausal women\u2014a clinical research center study","volume":"81","author":"Lovejoy","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib100","first-page":"4420","article-title":"Effects of methyltestosterone on insulin secretion and sensitivity in women","volume":"83","author":"Diamond","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib101","first-page":"265","article-title":"Induction of insulin resistance by androgens and estrogens","volume":"79","author":"Polderman","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib102","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0039-128X(00)00122-7","article-title":"Progestins and menopause: epidemiological studies of risks of endometrial and breast cancer","volume":"65","author":"Pike","year":"2000","journal-title":"Steroids"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib103","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0015-0282(00)00711-1","article-title":"Do androgens have a direct effect on endometrial function?","volume":"74","author":"Tuckerman","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib104","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1067\/mob.2001.109734","article-title":"Role of androgens in the growth of endometrial carcinoma: an in vivo animal model","volume":"184","author":"Legro","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib105","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0960-0760(95)00228-6","article-title":"Androgen receptor mediated growth control of breast cancer and endometrial cancer modulated by antiandrogen- and androgen-like steroids","volume":"56","author":"Hackenberg","year":"1996","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib106","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1002\/1097-0142(19930601)71:11<3565::AID-CNCR2820711117>3.0.CO;2-7","article-title":"The influence of progesterone and androgens on the growth of endometrial carcinoma","volume":"71","author":"Boman","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib107","first-page":"491","article-title":"Aromatase in human endometrial carcinoma and hyperplasia","volume":"146","author":"Watanabe","year":"1995","journal-title":"Am J Pathol"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib108","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0022-4731(85)90142-6","article-title":"Aromatization of androstenedione by normal and neoplastic endometrium of the uterus","volume":"22","author":"Yamaki","year":"1985","journal-title":"J Steroid Biochem"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib109","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/jnci\/88.16.1127","article-title":"Case-control study of endogenous steroid hormones and endometrial cancer","volume":"88","author":"Potischman","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib110","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0960-0760(93)90251-Q","article-title":"Estrogen productivity of endometrium and endometrial cancer tissue; influence of aromatase on proliferation of endometrial cancer cells","volume":"44","author":"Yamamoto","year":"1993","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib111","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ijc.11529","article-title":"Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women","volume":"108","author":"Lukanova","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib112","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jcem-62-1-16","article-title":"Histopathological effects of exogenously administered testosterone in 19 female to male transsexuals","volume":"62","author":"Futterweit","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib113","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14596-5","article-title":"Breast cancer and hormone-replacement therapy in the Million Women Study","volume":"362","author":"Beral","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib114","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0960-0760(00)00113-8","article-title":"Estrogens in the causation of breast, endometrial and ovarian cancers\u2014evidence and hypotheses from epidemiological findings","volume":"74","author":"Persson","year":"2000","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib115","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/jnci\/92.4.328","article-title":"Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin","volume":"92","author":"Ross","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib116","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1001\/jama.283.4.485","article-title":"Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk","volume":"283","author":"Schairer","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib117","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(02)11032-4","article-title":"Evidence from randomised trials on the long-term effects of hormone replacement therapy","volume":"360","author":"Beral","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib118","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/(SICI)1097-0215(19990505)81:3<339::AID-IJC5>3.0.CO;2-6","article-title":"Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy","volume":"81","author":"Magnusson","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib119","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1001\/jama.289.24.3243","article-title":"Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women\u2019s Health Initiative Randomized Trial","volume":"289","author":"Chlebowski","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib120","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1096\/fj.99-0863com","article-title":"Testosterone inhibits estrogen-induced mammary epithelial proliferation and suppresses estrogen receptor expression","volume":"14","author":"Zhou","year":"2000","journal-title":"Faseb J"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib121","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/bjc.1996.513","article-title":"Expression of the androgen receptor and an androgen-responsive protein, apolipoprotein D, in human breast cancer","volume":"74","author":"Hall","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib122","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/path.1711700106","article-title":"Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors","volume":"170","author":"Isola","year":"1993","journal-title":"J Pathol"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib123","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0960-0760(95)00005-K","article-title":"Androgens induce divergent proliferative responses in human breast cancer cell lines","volume":"52","author":"Birrell","year":"1995","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib124","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0960-0760(01)00154-6","article-title":"The potential role of estrogen in aromatase regulation in the breast","volume":"79","author":"Yue","year":"2001","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib125","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF01187162","article-title":"Aromatase in breast cancer tissue\u2014localization and relationship with reproductive status of patients","volume":"122","author":"Berstein","year":"1996","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib126","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1200\/JCO.1992.10.3.438","article-title":"Aromatase activity and estradiol in human breast cancer: its relationship to estradiol and epidermal growth factor receptors and to tumor-node-metastasis staging","volume":"10","author":"Bolufer","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib127","first-page":"1460","article-title":"Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients","volume":"81","author":"Pasqualini","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib128","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1210\/er.2003-0016","article-title":"Testosterone effects on the breast: implications for testosterone therapy for women","volume":"25","author":"Somboonporn","year":"2004","journal-title":"Endocr Rev"},{"issue":"Suppl 4","key":"10.1016\/j.fertnstert.2007.01.118_bib129","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/S0015-0282(02)02979-5","article-title":"Androgens and mammary growth and neoplasia","volume":"77","author":"Dimitrakakis","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib130","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/01.GME.0000055522.67459.89","article-title":"A physiologic role for testosterone in limiting estrogenic stimulation of the breast","volume":"10","author":"Dimitrakakis","year":"2003","journal-title":"Menopause"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib131","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/jnci\/djh336","article-title":"Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women","volume":"96","author":"Missmer","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib132","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/jnci\/djj011","article-title":"Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1)","volume":"98","author":"Beattie","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib133","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/jnci\/88.5.291","article-title":"Serum sex hormone levels after menopause and subsequent breast cancer","volume":"88","author":"Berrino","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib134","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/jnci\/90.17.1292","article-title":"Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women","volume":"90","author":"Hankinson","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib135","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1093\/oxfordjournals.aje.a009059","article-title":"Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women","volume":"145","author":"Zeleniuch-Jacquotte","year":"1997","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib136","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/oxfordjournals.aje.a114596","article-title":"Sex hormone levels in serum in relation to the development of breast cancer","volume":"125","author":"Wysowski","year":"1987","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib137","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/oxfordjournals.aje.a116228","article-title":"Sex hormones and postmenopausal breast cancer: a prospective study in an adult community","volume":"135","author":"Garland","year":"1992","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib138","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/bjc.1997.398","article-title":"A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guernsey","volume":"76","author":"Thomas","year":"1997","journal-title":"Br J Cancer"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib139","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/sj.bjc.6601517","article-title":"Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study","volume":"90","author":"Zeleniuch-Jacquotte","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib140","doi-asserted-by":"crossref","first-page":"270","DOI":"10.7326\/0003-4819-130-4_Part_1-199902160-00004","article-title":"Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer","volume":"130","author":"Cauley","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib141","first-page":"45","article-title":"Serum levels of sex hormones and breast cancer risk in premenopausal women: a case-control study (USA)","volume":"15","author":"Sturgeon","year":"2004","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib142","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1002\/ijc.22203","article-title":"Serum concentrations of estrogens, sex hormone-binding globulin, and androgens and risk of breast cancer in postmenopausal women","volume":"119","author":"Adly","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib143","first-page":"533","article-title":"Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk","volume":"5","author":"Dorgan","year":"1996","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib144","first-page":"599","article-title":"Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden)","volume":"14","author":"Manjer","year":"2003","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib145","first-page":"1067","article-title":"Joint effect of insulin-like growth factors and sex steroids on breast cancer risk","volume":"12","author":"Yu","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib146","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/ijc.11034","article-title":"Plasma sex steroid hormones and breast cancer risk in Chinese women","volume":"105","author":"Yu","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib147","first-page":"403","article-title":"Chronic anovulation syndrome and associated neoplasia","volume":"61","author":"Coulam","year":"1983","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib148","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/(SICI)1097-0142(19970201)79:3<494::AID-CNCR10>3.0.CO;2-Z","article-title":"Association of Stein-Leventhal syndrome with the incidence of postmenopausal breast carcinoma in a large prospective study of women in Iowa","volume":"79","author":"Anderson","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib149","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/oxfordjournals.aje.a116156","article-title":"Polycystic ovaries and the risk of breast cancer","volume":"134","author":"Gammon","year":"1991","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib150","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1001\/archinte.166.14.1483","article-title":"Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women","volume":"166","author":"Tamimi","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib151","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/bjc.1986.246","article-title":"Menopausal oestrogens and breast cancer risk: an expanded case-control study","volume":"54","author":"Brinton","year":"1986","journal-title":"Br J Cancer"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib152","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/ijc.2910420606","article-title":"Influence of non-contraceptive exogenous and endogenous sex hormones on breast cancer risk in Denmark","volume":"42","author":"Ewertz","year":"1988","journal-title":"Int J Cancer"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib153","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/01.GME.0000119983.48235.D3","article-title":"Breast cancer incidence in postmenopausal women using testosterone in addition to usual hormone therapy","volume":"11","author":"Dimitrakakis","year":"2004","journal-title":"Menopause"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib154","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/path.1711700107","article-title":"An immunohistochemical study of the long-term effects of androgen administration on female-to-male transsexual breast: a comparison with normal female breast and male breast showing gynaecomastia","volume":"170","author":"Burgess","year":"1993","journal-title":"J Pathol"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib155","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/01.gme.0000232033.92411.51","article-title":"Testosterone inhibits estrogen\/progestogen-induced breast cell proliferation in postmenopausal women","volume":"14","author":"Hofling","year":"2007","journal-title":"Menopause"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib156","first-page":"262","article-title":"Liver damage from long-term methyltestosterone","volume":"2","author":"Westaby","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib157","series-title":"Pediatric endocrinology: mechanisms, manifestations, and management","first-page":"231","article-title":"Molecular genetic control of sex differentiation","author":"Lee","year":"2004"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib158","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0015-0282(16)33722-0","article-title":"The effects of androgens on fetal sexual development: androgen-induced female pseudohermaphrodism","volume":"11","author":"Grumbach","year":"1960","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib159","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1001\/jama.1960.03020100036007","article-title":"Masculinization of female fetus due to use of orally given progestins","volume":"172","author":"Wilkins","year":"1960","journal-title":"JAMA"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib160","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1210\/jcem-19-11-1369","article-title":"On the fetal masculinizing action of certain oral progestins","volume":"19","author":"Grumbach","year":"1959","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib161","first-page":"627","article-title":"Male external genitalia of a girl caused by a virilizing adrenal tumour in the mother","volume":"65","author":"M\u00fcrset","year":"1970","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib162","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0022-3476(73)80598-0","article-title":"Female pseudohermaphroditism secondary to a maternal virilizing tumor","volume":"82","author":"Haymond","year":"1973","journal-title":"J Pediatr"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib163","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1210\/jcem-70-5-1280","article-title":"Female pseudohermaphroditism due to a maternal adrenocortical tumor","volume":"70","author":"Kirk","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib164","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/archpedi.1982.03970400071018","article-title":"Fetal and maternal virilization associated with pregnancy","volume":"136","author":"Cohen","year":"1982","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib165","first-page":"930","article-title":"Normal female infants born of mothers with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"84","author":"Lo","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib166","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1210\/jcem-40-5-816","article-title":"Fetal protection against masculinization with hyperreactio luteinalis and virilization","volume":"40","author":"Hensleigh","year":"1975","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib167","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0015-0282(16)54828-6","article-title":"Gestational hyperandrogenism","volume":"57","author":"McClamrock","year":"1992","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib168","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1210\/endo.130.5.1572292","article-title":"Increasing aromatase cytochrome P-450 level in human placenta during pregnancy: studied by immunohistochemistry and enzyme-linked immunosorbent assay","volume":"130","author":"Kitawaki","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib169","first-page":"260","article-title":"Markedly elevated serum testosterone in pregnancy without fetal virilization","volume":"63","author":"Berger","year":"1984","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib170","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1210\/jcem-72-3-560","article-title":"A new cause of female pseudohermaphroditism: placental aromatase deficiency","volume":"72","author":"Shozu","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib171","first-page":"1287","article-title":"A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom)","volume":"78","author":"Conte","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib172","first-page":"3689","article-title":"Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens","volume":"80","author":"Morishima","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib173","first-page":"1739","article-title":"Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the P450arom gene: impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries, and bone densitometry in childhood","volume":"82","author":"Mullis","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib174","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2265.1994.tb02478.x","article-title":"Longitudinal study of maternal plasma bioavailable testosterone and androstanediol glucuronide levels during pregnancy","volume":"40","author":"Kerlan","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib175","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/ar.1091570402","article-title":"The antiestrogenic and antiandrogenic activities of progesterone in the defense of a normal fetus","volume":"157","author":"Dorfman","year":"1967","journal-title":"Anat Rec"},{"key":"10.1016\/j.fertnstert.2007.01.118_bib176","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1210\/jcem-38-1-142","article-title":"Inhibition of testosterone conversion to dihydrotestosterone in men treated percutaneously by progesterone","volume":"38","author":"Mauvais-Jarvis","year":"1974","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028207002816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028207002816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T07:19:08Z","timestamp":1758007148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028207002816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":176,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S0015028207002816"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2007.01.118","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of testosterone treatment in postmenopausal women","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2007.01.118","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}